BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26096942)

  • 1. Growth inhibition of luteolin on HepG2 cells is induced via p53 and Fas/Fas-ligand besides the TGF-β pathway.
    Yee SB; Choi HJ; Chung SW; Park DH; Sung B; Chung HY; Kim ND
    Int J Oncol; 2015 Aug; 47(2):747-54. PubMed ID: 26096942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines.
    Hsu YL; Kuo PL; Chiang LC; Lin CC
    Cancer Lett; 2004 Sep; 213(2):213-21. PubMed ID: 15327837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells.
    Hung JY; Yang CJ; Tsai YM; Huang HW; Huang MS
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):141-7. PubMed ID: 17941899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
    Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
    Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells.
    Liu B; Shi Y; Peng W; Zhang Q; Liu J; Chen N; Zhu R
    Mol Med Rep; 2016 Jul; 14(1):159-64. PubMed ID: 27176768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Arctigenin-Induced Specific Cytotoxicity against Human Hepatocellular Carcinoma Cell Lines: Hep G2 and SMMC7721.
    Lu Z; Cao S; Zhou H; Hua L; Zhang S; Cao J
    PLoS One; 2015; 10(5):e0125727. PubMed ID: 25933104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells.
    Yuan L; Wei S; Wang J; Liu X
    J Agric Food Chem; 2014 Jun; 62(23):5390-400. PubMed ID: 24841907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol extract from Cnidium monnieri (L.) Cusson induces cell cycle arrest and apoptosis via regulation of the p53‑independent pathway in HepG2 and Hep3B hepatocellular carcinoma cells.
    Lim EG; Kim GT; Kim BM; Kim EJ; Kim SY; Kim YM
    Mol Med Rep; 2018 Feb; 17(2):2572-2580. PubMed ID: 29207130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated actinomycin D, a novel actinomycin D analog induces apoptosis in HepG2 cells through Fas- and mitochondria-mediated pathways.
    Chen Y; Liu J; Yuan B; Cao C; Qin S; Cao X; Bian G; Wang Z; Jiang J
    Mol Carcinog; 2013 Dec; 52(12):983-96. PubMed ID: 22821714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells.
    Yingkun N; Lvsong Z; Huimin Y
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1138-46. PubMed ID: 21164560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells.
    Cheng SB; Wu LC; Hsieh YC; Wu CH; Chan YJ; Chang LH; Chang CM; Hsu SL; Teng CL; Wu CC
    J Agric Food Chem; 2012 Sep; 60(38):9620-30. PubMed ID: 22946656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of apoptosis and autophagy by luteolin in human hepatocellular cancer Hep3B cells.
    Lee Y; Kwon YH
    Biochem Biophys Res Commun; 2019 Oct; 517(4):617-622. PubMed ID: 31383362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells.
    Wang Y; Wang C; Jiang C; Zeng H; He X
    Sci Rep; 2015 Dec; 5():18613. PubMed ID: 26678950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation.
    Androutsopoulos VP; Spandidos DA
    J Nutr Biochem; 2013 Feb; 24(2):496-504. PubMed ID: 22749133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis.
    Sharula ; Wu Z
    Anticancer Agents Med Chem; 2017; 17(7):941-947. PubMed ID: 28356025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells.
    Shieh DE; Chen YY; Yen MH; Chiang LC; Lin CC
    Life Sci; 2004 Mar; 74(18):2279-90. PubMed ID: 14987952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of luteolin isolated from Ixeris sonchifolia Hance on the proliferation of HepG2 human hepatocellular carcinoma cells.
    Yee SB; Lee JH; Chung HY; Im KS; Bae SJ; Choi JS; Kim ND
    Arch Pharm Res; 2003 Feb; 26(2):151-6. PubMed ID: 12643593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for the Fas-/Fas-Ligand pathway in chemoresistance of human squamous cell carcinomas of the head and neck (SCCHN)?
    Sproll KC; Balló H; Hoffmann TK; Scheckenbach K; Koldovsky U; Balz V; Hafner D; Ramp U; Bier H
    Oral Oncol; 2009 Jan; 45(1):69-84. PubMed ID: 18620901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.